Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Peripheral blood gene expression profile of atherosclerotic coronary artery disease in patients of different ethnicity in Malaysia.

Abdullah MH, Othman Z, Noor HM, Arshad SS, Yusof AK, Jamal R, Rahman AR.

J Cardiol. 2012 Sep;60(3):192-203. doi: 10.1016/j.jjcc.2012.05.009.

2.

The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.

Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, Berni A, Baroni MG.

Nutr Metab Cardiovasc Dis. 2006 Jul;16(5):345-52.

PMID:
16829343
3.

Gene expression profiling in ethnic Malays with type 2 diabetes mellitus, with and without diabetic nephropathy.

Lokman FE, Seman NA, Ismail AA, Yaacob NA, Mustafa N, Khir AS, Hussein Z, Wan Mohamud WN.

J Nephrol. 2011 Nov-Dec;24(6):778-89. doi: 10.5301/JN.2011.6382.

PMID:
21360476
4.

Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis.

Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, Elashoff MR, Rosenberg S, Buellesfeld L, Grube E, Newby LK, Ginsburg GS, Kraus WE.

Circ Cardiovasc Genet. 2008 Oct;1(1):31-8. doi: 10.1161/CIRCGENETICS.108.782730.

5.

Decreased gene expression of LC3 in peripheral leucocytes of patients with coronary artery disease.

Wu G, Wei G, Huang J, Pang S, Liu L, Yan B.

Eur J Clin Invest. 2011 Sep;41(9):958-63. doi: 10.1111/j.1365-2362.2011.02486.x.

PMID:
21812771
6.

The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years).

Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M, Fallarino M, Sorropago G, Baroni MG.

J Mol Med (Berl). 2005 Sep;83(9):711-9.

PMID:
15877215
7.
8.

Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the Polish population.

Gorący J, Gorący I, Safranow K, Taryma O, Adler G, Ciechanowicz A.

Arch Med Res. 2011 Jul;42(5):426-32. doi: 10.1016/j.arcmed.2011.08.002.

PMID:
21840356
9.

C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease.

Pasalić D, Marinković N, Grsković B, Ferencak G, Bernat R, Stavljenić-Rukavina A.

Mol Biol Rep. 2009 Apr;36(4):775-80. doi: 10.1007/s11033-008-9244-1.

PMID:
18401567
10.

A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial.

Lansky A, Elashoff MR, Ng V, McPherson J, Lazar D, Kraus WE, Voros S, Schwartz RS, Topol EJ.

Am Heart J. 2012 Sep;164(3):320-6. doi: 10.1016/j.ahj.2012.05.012.

PMID:
22980297
12.

Dysregulated gene expression of extracellular matrix and adhesion molecules in saphenous vein conduits of hemodialysis patients.

Sun Y, Ding W, Wei Q, Shen Z, Wang C.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):684-9. doi: 10.1016/j.jtcvs.2011.12.037.

14.

Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients.

Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, Lio D, Mocchegiani E.

Biogerontology. 2006 Oct-Dec;7(5-6):347-56.

PMID:
16953332
15.

Deep proteome profiling of circulating granulocytes reveals bactericidal/permeability-increasing protein as a biomarker for severe atherosclerotic coronary stenosis.

Bleijerveld OB, Wijten P, Cappadona S, McClellan EA, Polat AN, Raijmakers R, Sels JW, Colle L, Grasso S, van den Toorn HW, van Breukelen B, Stubbs A, Pasterkamp G, Heck AJ, Hoefer IE, Scholten A.

J Proteome Res. 2012 Nov 2;11(11):5235-44. doi: 10.1021/pr3004375.

PMID:
23020738
16.

VEGF gene mRNA expression in patients with coronary artery disease.

Amoli MM, Amiri P, Alborzi A, Larijani B, Saba S, Tavakkoly-Bazzaz J.

Mol Biol Rep. 2012 Sep;39(9):8595-9. doi: 10.1007/s11033-012-1713-x.

PMID:
22711306
17.

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.

Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK.

Circulation. 2004 Apr 27;109(16):1966-72.

18.

Different impact of deletion polymorphism of gene on the risk of renal and coronary artery disease.

Olivieri O, Grazioli S, Pizzolo F, Stranieri C, Trabetti E, Beltrame F, Girelli D, Pignatti PF, Corrocher R.

J Hypertens. 2002 Jan;20(1):37-43.

PMID:
11791024
19.

Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease.

Arman A, Soylu O, Yildirim A, Furman A, Ercelen N, Aydogan H, Coker A, Tezel T.

Arq Bras Cardiol. 2008 Nov;91(5):293-8. English, Portuguese.

20.

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.

Cavallari U, Trabetti E, Malerba G, Biscuola M, Girelli D, Olivieri O, Martinelli N, Angiolillo DJ, Corrocher R, Pignatti PF.

BMC Med Genet. 2007 Sep 5;8:59.

Supplemental Content

Support Center